Email not displaying properly? View email in your browser
Vertical-Talk Pharma    Vaccine Adjuvants
 Calcitonin Gene-related Peptide
 Reversal of Factor Xa Inhibitors
Aug 2018   e-Newsletter Archives    |    Advertise
Follow Us Facebook Twitter Google Plus Linkedin
CPhI Middle East & Africa
News
Astellas announces acquisition of Quethera
BioNTech Signs Collaboration Agreement...
Tolero Pharmaceuticals Announces Clinical...
 
Press Releases
Agena Bioscience Announces Collaboration...
Pfizer and Astellas Amend Clinical Research...
Roche receives FDA approval for cobas EGFR...
 
Events
03 -05 Sep 2018
CPhI Middle East & Africa
10 -12 Sep 2018
Global Health Exhibition
11 -12 Sep 2018
FlyPharma Conference US
Articles
  Vaccine Adjuvants
Mansoor M Amiji, Professor, Pharmaceutical Sciences at Northeastern University, Boston
Adjuvants are immune potentiators administered concurrently with antigens in order to boost vaccine efficacy. The need for vaccine adjuvants was established after discovery of safe, highly purified, but less...
EVA Pharmacare
Techno Trends
 Amgen and Novartis Pharma Collaborate to Develop Novel Approach...
  Portola Pharmaceuticals Introduces Antidote for the Reversal of Factor...
Vetter Pharma
Projects
  Sterling Pharma Solutions to Invest US$8 million in Pilot Plant Facility...
 Lonza Opens World’s Largest Dedicated Cell-and-Gene-Therapy...
FPS
e-Magazine  |  Subscribe  |  Unsubscribe  |  Previous Issues  |  Advisory Board  |  Editorial Calendar  |  Media Pack
www.pharmafocusasia.com - Owned by Ochre Media Pvt. Ltd.
Tel: +91 40 4961 4567 | Fax: +91 40 4961 4555